• 3-Alpha Androstanediol Glucuronide
  • MUTYH Gene Mutation Analysis (Y165C and G382D) for MUTYH associated polyposis (MAP)
  • Lysosomal Acid Lipase, Gene Variation
  • MLH3 Gene Mutation Analysis
  • Chromium, 24 Hour, Urine
  • Phenosense HIV Drug Resistance Replication Capacity
  • Alpha Lactalbumin IgG
  • Vanillylmandelic Acid (VMA) and Homovanillic Acid (HVA), Random, Urine
  • Hereditary Hemorrhagic Telangiectasia, ENG Gene Mutation Analysis
  • Soluble Fibrin Monomer
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Signatera™ for Minimal Residual Disease (MRD)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Signatera™ for Minimal Residual Disease (MRD)
Medical Test

Specimen Collection
Access to Signatera™ for Minimal Residual Disease (MRD) is restricted.